When endocrinologist Dan Bessesen, MD, looked online and saw how easy it would be for him to purchase a weight loss drug from ...

Health Canada is reviewing nine submissions for generic versions of semaglutide, a prescription medication sold under Novo ...

A review of surgical tourism found people can spend several weeks in NHS hospitals when they return home from having procedures.

An illness connecting heart disease, kidney problems, diabetes, and obesity is a major high-risk health cycle affecting ...

Most U.S. adults have risk factors tied to a little-known condition called CKM syndrome, which connects heart disease, kidney ...

Obesity is one of the most serious and ubiquitous health problems worldwide. Obesity can be defined as a multifactorial ...

Algorithms in clinical decision tools have been making it harder for certain racial and socioeconomic groups to receive the healthcare they deserve.

They’re in your pans, your makeup and your clothes — and now, scientists say they may be quietly putting teens at risk.

Over 27 percent of adults worldwide with obesity qualify for GLP-1 weight loss medicines but access remains unequal.

The media superstar, who has struggled with weight for much of her life, and a Yale School of Medicine doctor team up for a ...

Many people who stop using weight loss drugs will return to their previous weight within two years, a new review of existing ...

The cost, the shortages, and even the side effects have led to older people who start Ozempic, Wegovy, and similar drugs to ...